N-(4-Fluorobenzyl)-5-hydroxy-1-(methyl-d3)-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide potassium salt
Raltegravir-D3 Potassium Salt is a fully characterized chemical compound used as a reference standard of API Raltegravir. The standard offered is compliant with regulatory guidelines. Raltegravir-D3 Potassium Salt is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1246816-98-7
